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Znf703 is a novel RA target in the 
neural plate border
Amanda Janesick  1,3, Weiyi tang  1,4, Kristen Ampig1 & Bruce Blumberg  1,2
Znf703 is an RAR- and Wnt-inducible transcription factor that exhibits a complex expression pattern 
in the developing embryo: Znf703 mRNA is found in the early circumblastoporal ring, then later 
throughout the neural plate and its border, and subsequently in the mid/hindbrain and somites. We 
show that Znf703 has a different and separable function in early mesoderm versus neural crest and 
placode development. Independent of its early knockdown phenotype on Gdf3 and Wnt8, Znf703 
disrupts patterning of distinct neural crest migratory streams normally delineated by Sox10, Twist, 
and Foxd3 and inhibits otocyst formation and otic expression of Sox10 and Eya1. Furthermore, Znf703 
promotes massive overgrowth of SOX2+ cells, disrupting the SoxB1 balance at the neural plate border. 
Despite prominent expression in other neural plate border-derived cranial and sensory domains, Znf703 
is selectively absent from the otocyst, suggesting that Znf703 must be specifically cleared or down-
regulated for proper otic development. We show that mutation of the putative Groucho-repression 
domain does not ameliorate Znf703 effects on mesoderm, neural crest, and placodes. We instead 
provide evidence that Znf703 requires the Buttonhead domain for transcriptional repression.
The neural plate border and non-neural ectoderm comprise a narrow arc of multipotent cells that circumscribe 
the neural plate1. Although cells of different lineages are comingled in this region early, they eventually segregate 
into neural, placodal, neural crest, and epidermal fates1–3. Znf703 belongs to a highly conserved family of NET 
(Noc, Nlz, Elbow, and Tlp-1) zinc finger transcriptional repressors and was previously studied in zebrafish, pri-
marily in the mid/hindbrain4,5. Znf703 was recently shown to be expressed in the neural plate border of Xenopus 
where it partially overlaps with presumptive neural crest (Snai2)6. We recently identified Znf703 as a target of 
RARγ7, prompting further investigation into the role of Znf703 in early developmental processes that are sensitive 
to retinoic acid, such as neural crest and placodal patterning.
Because it is expressed at the neural plate border, Znf703 protein is positioned to interact with a variety of 
signaling pathways. Znf703 inhibits Wnt and Tgfβ signaling in vitro8,9, and reciprocally, Znf703 is a direct target 
of Wnt/β-catenin signaling in 293 T human embryonic kidney (HEK) cells, mouse, and Xenopus embryos8,10,11. 
There is also evidence that Znf703 is a direct target of T (Brachyury) in both mouse and Xenopus12,13. Furthermore, 
Znf703 is induced by retinoic acid (RA) signaling in early and late zebrafish gastrula embryos14. We recently 
showed that activation of RARγ1 is required for Znf703 expression at gastrula stage7.
Here we show that Znf703 is strongly modulated by RA throughout development: Znf703 mRNA is vastly 
expanded dorsally and rostrally by RA, obliterating the mid-hindbrain and neural plate border boundaries. We 
further show that mis/overexpression of Znf703 blurs the Sox10 expression domain such that normally segregated 
migratory streams (branchial, hyoid and mandibular) of neural crest are collapsed, aggregated, and devoid of 
overt patterning. We found that mis/overexpression of Znf703 causes a massive expansion of SOX2+ cells, while 
inhibiting expression of the placode marker, Eya1 as well as otic Sox10 expression. This results in the shrinkage or 
disappearance of the hollow ball of ectoderm that delineates an otocyst. Towards Znf703 function, we investigated 
the highly conserved FKPY domain of Znf703 and found that mutation of FKPY had minimal effect on transcrip-
tional repression and developmental phenotypes compared to wild type, but that the buttonhead domain was 
indispensable for repression by Znf703. Finally, we show that phenotypes on otic and neural crest development 
are separable from early loss of mesodermal markers Gdf3 and Wnt8. Hence, despite early phenotypes that could 
potentially affect neural crest competence, Znf703 is still able to influence neural crest and placode patterning 
when overexpressed after gastrulation.
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Methods
Phylogenetic tree. The Noc-family phylogenetic tree was constructed by aligning sequences with the 
MAFFT v7.306b (E-INS-i algorithm)15, then creating the tree using default settings, with bootstrap resampling 
set to 100016. The resultant tree was drawn with FigTree v1.4.2, rooting at the midpoint17.
Embryo microinjection, treatment, and in situ hybridization. All experiments in Xenopus were per-
formed in accordance with the relevant guidelines and regulations, and approved by the Institutional Animal 
Care and Use Committee of the University of California, Irvine. Xenopus eggs were fertilized in vitro and embryos 
staged as described18. Embryos were microinjected bilaterally or unilaterally at the two- or four-cell stage with 
Znf703 (WT, mutant or inducible) mRNA together with 100 pg/embryo β-galactosidase (β-gal) mRNA lineage 
tracer (LT). Embryos were maintained in 0.1x MBS until appropriate stages. Embryos processed for whole-mount 
in situ hybridization (WISH) were fixed in MEMFA, stained with magenta-GAL (Biosynth), and then stored in 
100% EtOH18. We reverse transcribed (Life Technologies) and sequenced the mRNA we microinjected to verify 
the identity of each Znf703 mRNA microinjected. For chemical treatments (DEX or TTNPB), embryos were 
transferred in groups of 25 to 60-mm glass Petri dishes with 10 mL of 0.1X MBS containing chemicals at the fol-
lowing concentrations: 5 μM dexamethasone or corresponding vehicle control (0.05% DMSO); 1 μM TTNPB or 
corresponding vehicle control (0.1% EtOH).
Whole mount in situ hybridization was performed on microinjected embryos as previously described18. All 
probes were prepared via PCR amplification of protein coding regions (~500–800 bp) from either cDNA or 
library clones with a bacteriophage T7 promoter at the 3′ end. Relevant primers are listed in Table S1. Probes were 
transcribed with MEGAscript® T7 (Life Technologies) in the presence of digoxigenin-11-UTP (Roche). Double 
WISH was conducted as previously described18. RT-QPCR was conducted as previously described19, and relevant 
primers are listed in Table S2.
Immunohistochemistry on vibratome sections and whole mounts. Embryos were embedded, 
sectioned and stained and embedded as described7. Transverse sections were labeled with primary antibody 
anti-SOX2 E-4 (1:100; Santa Cruz Biotechnology) followed by secondary antibody anti-mouse-647 (1:200; 
ThermoFisher) and DAPI nuclear stain (1:2000). Whole mount preparations were stained with DAPI, followed 
by clearing and mounting in Scale A220. Embryos were imaged on the Zeiss LSM880 confocal microscope at 20X 
magnification as described previously7.
Transient transfection and luciferase assays. pCDG1-Znf703 was constructed by PCR amplifica-
tion of the protein-coding regions of Xenopus laevis cDNA and cloned into the NcoI-BamHI site of pCDG1. 
pCDG1-Znf703 mutant constructs were made by two-fragment PCR (primers listed in Table S3) to generate the 
conservative FKPY→LQAF21, or non-conservative FKPY→AAAA substitutions. pCDG1-Znf703 clones were 
sequence verified, and linearized with NotI. 5′-capped mRNA was transcribed using T7 mMESSAGE mMA-
CHINE® Kit (Thermo Fisher Scientific). pCMX-Gal-Znf703 constructs were constructed by PCR amplification 
of pCDG1-Znf703 and cloned into the EcoRI-BamHI site of pCMX-Gal422 (primers listed in Table S4). COS7 
cells were transiently transfected with Gal constructs as previously described23. Data are reported as normalized 
luciferase ± S.E.M. where reduction of luciferase activity compared to Gal4 alone indicates transcriptional repres-
sion. Statistical significance was determined using one-way ANOVA and Bonferroni post-hoc test in GraphPad 
Prism v5.0.
Results
Znf703 is a highly conserved transcriptional repressor that exhibits a complex expression pat-
tern in mesoderm, neural plate, and mid/hindbrain. Znf703 and Znf503 are members of the NET 
(Noc, Nlz, Elbow, and Tlp-1) family of zinc finger transcriptional repressors. We constructed a phylogenic tree 
of representative members of the NET family and show that orthologs of Znf703 and Znf503 occur in a diverse 
number of taxonomic groups (Fig. 1A). ZNF703 and ZNF503 proteins have a conserved FKPY motif which was 
predicted to recruit Groucho based on its similarity to Brinker and Elbow FKPY24,25 and Hucklebein FRPW26. 
We performed transient transfection assays using four different Gal4 effector constructs, mutating the putative 
Groucho-interacting domain of Xenopus Znf703 from FKPY to LQAF, or serially deleting the proline rich and 
buttonhead domains (Fig. 1B). We assayed the ability of these constructs to induce luminescence using a Gal4-
luciferase reporter. Reduction of luciferase activity compared to Gal4 alone indicates transcriptional repression 
by ZNF703. Only deletion past the buttonhead domain relieved repression by ZNF703 (Fig. 1B). The buttonhead 
domain is highly conserved across all species shown in Fig. 1A, with the two cysteine and proline residues never 
deviating from the consensus (Fig. 1C). Although neither function nor interacting partners have been character-
ized for the buttonhead domain, we infer that this domain is likely to be required for transcriptional repression 
by ZNF703.
We characterized Xenopus expression of Znf703 (Fig. 2A–C) and Znf503 (Fig. 2B, S1) expression over devel-
opmental time. Znf703 and Znf503 are expressed in the circumblastoporal ring of the stage 10 gastrula, but absent 
from the organizer, reminiscent of Ventx2 or Wnt8 expression domains. At stage 14, Znf703 is expressed broadly 
in both the neural plate and the border zone, but is absent from the anterior. By stage 19, Znf703 is expressed in 
the eye/forebrain, absent from r1/r2, then forms a sharp boundary at r3/r4, as shown previously6. We also per-
formed WISH for Znf503 expression, which is weaker and less sharp, but generally shows a similar expression 
pattern to Znf703, albeit without anterior expression at neurula stage (Fig. S1). Xenbase expression data is not 
available for X. laevis Znf503, but X. tropicalis shows a 10-to-17-fold magnitude difference in transcript counts 
between Znf703 and the lower expressed Znf503 at stages 11–12.5. Our QPCR expression analysis in X. laevis 
verifies that Znf703 is more highly expressed than Znf503 (Fig. 2B).
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Double WISH revealed that Znf703 expression overlaps with En2 and Krox2 (Fig. 2C). This mid-hindbrain 
expression is concordant with zebrafish expression data where Nlz1 is found at both the mid-hindbrain bound-
ary, and the hindbrain, but only as rostral as rhombomere 3, and later expanding to rhombomere 25,14,27. In 
chick embryos, Znf703 also yields sharp boundaries of expression in the hindbrain at E2.5 (~HH14) (Fig. 2D). 
The murine ortholog, Zfp703, also shows similar expression to chicken8. These results demonstrate that Znf703 
sequence and spatial expression are highly conserved among fish, birds, amphibians, and mammals.
Znf703 is modulated by RA. In Janesick, Tang et al., 2018, we identified Znf703 as a target of RAR signa-
ling by RNA-seq and showed that RARγ1 was required for its expression in the Xenopus gastrula. Treatment at 
stage 6/7 with 1 µM of the RAR-selective agonist, TTNPB, showed that Znf703 is responsive to modulation of 
RAR signaling across developmental time (Fig. 3). Znf703 is normally absent from the organizer, but is ectopically 
expanded in the presence of TTNPB. By stage 16, TTNPB causes Znf703 to be expressed throughout the embryo 
such that the normal anterior boundary of Znf703 is obliterated–this continues throughout stages 20 and 30. 
Treatment with the RAR-selective antagonist, AGN193109, elicited only subtle alterations in Znf703 expression 
(data not shown).
Znf703 effect on early mesoderm is separable from its disruption of placode and neural crest 
patterning. Recent data has shown that modulation of Znf703 activity affects neural crest markers Sox10 and 
Snai26. When Znf703 is overexpressed, we observed knockdown of early neural crest markers Foxd3 and Tfap2a 
(Fig. S2). At later stages, Sox10, Twist, and Foxd3 expression domains do not separate into distinct migratory 
Figure 1. Znf703 is a conserved transcriptional repressor. (A) Phylogenetic tree of Znf703 sequences aligned 
and constructed with MAFFT (see materials and methods). The scale bar represents the divergence distance 
of 0.2 amino acid substitutions per site of the Znf703 sequence. The tree segregates organisms appropriately 
with the exception of Amphioxus. We attempted to add more sequences to improve this unexpected result, 
but Amphioxus persistently segregated with mollusk sequences. (B) Cos7 cells were transfected with 5:5:1 
DNA ratio of reporter (Gal4-Luc): β-gal: effector (Znf703). The y-axes represent relative light units measured 
by the luminometer normalized to β-gal activity. Basal reporter activity (Gal4 alone) is repressed by Znf703. 
Mutating the FKPY domain or deletion of the N-terminus up until the Buttonhead (Btd) domain still represses 
transcriptional activity. Deletion beyond the Btd domain relieves repression. Statistical significance was 
determined using one-way ANOVA, and Bonferroni post-hoc test in GraphPad Prism v5.0 (***P ≤ 0.001).  
(C) Conservation of the Btd domain across the animal kingdom, visualized with WebLogo66.
4Scientific RepoRts |          (2019) 9:8275  | https://doi.org/10.1038/s41598-019-44722-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
streams, compared to the uninjected side (Fig. 4A–C). Rather, the cells marked by Sox10, Twist, and Foxd3 are 
aggregated together with no discernible pattern. By tailbud stage, this effect is further manifested in the lack of 
ventral migration of crest markers into the epibranchial domain (Fig. 4D’-F’). Manipulation of the FKPY (puta-
tive Groucho) domain of Znf703 did not affect the overexpression phenotype of Znf703 on the markers we tested 
(Fig. S3).
Manipulation of Znf703 yields nearly identical phenotypes in loss-of-function and gain-of-function exper-
iments6. Such outcomes can often be ascribed to the manipulation of a gene that has a different function early 
versus late in development, and disrupting both functions can confound interpretation of results28. Znf703 is 
such a gene since it is expressed in early mesoderm (Fig. 2A). Mis/overexpression of Znf703 yields selective loss 
of mesodermal markers Wnt8 and Gdf3 (Fig. 5A,B) without affecting T/Brachyury or Fgf8 (Fig. 5C,F); control 
mRNA (mCherry) did not alter Wnt8 or Gdf3 expression (Fig. 5D,E). There is ample evidence that early blastula 
and gastrula stage events (mesoderm formation, hypoblast signaling, pluripotency retention, etc.) contribute 
Figure 2. Expression of Znf703 and Znf503 across developmental time. (A) Whole mount in situ hybridization 
of Znf703 expression at Nieuwkoop and Faber developmental stages 11 (vegetal view, dorsal at the top), 14 
(dorsal view, anterior on the left), 19 (dorsal and anterior views), and 25 (lateral and dorsal views, anterior 
on the right). WISH of Znf503 expression can be found in Fig. S1. (B) Double WISH at stage 19 reveals the 
spatial relationship between Znf703 and midbrain (Engrailed 2) and hindbrain (Krox20) markers. (C) Znf703 
expression in a chick embryo at Hamburger Hamilton (HH) Stage 16 (lateral view; anterior on the right). 
MB = midbrain; HB = hindbrain. (D) QPCR showing Znf703 and Znf503 gene expression averaging two 
biological replicates over developmental time. Error bars = S.E.M. The y-axis represents 2−ΔCt values (adjusted 
for primer efficiency), normalized to reference gene, Histone H4.
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to neural crest and placode development29–33. We hypothesized that early loss of Wnt8 and/or Gdf3 could con-
tribute to the effect of Znf703 on neural crest patterning. To test this hypothesis, we designed dexamethasone 
(DEX)-inducible34 hGR-Znf703 constructs to separate the effects of Znf703 at gastrula, neurula and tailbud 
stages (Fig. 6A). A preliminary titration revealed the dose of mRNA (0.2 ng) needed to avoid saturation of the 
heat-shock protein which tethers hGR-Znf703 outside of the nucleus until DEX binding. This is the dose at which 
we observed no effect on Sox10 expression in vehicle (DMSO) treated embryos (Fig. S4).
When Znf703 expression was induced prior to gastrulation (stage 8) we observed loss of Wnt8 and Gdf3 
(Fig. S5), confirming that the hGR-Znf703 construct yields the same results as wildtype Znf703. When Znf703 
is induced after gastrulation (stage 12 or 15), neural crest gene expression is not noticeably altered at stage 18 
Figure 3. Znf703 expression is modulated by RAR-selective agonist TTNPB. WISH from embryos treated at 
stage 6/7 with 1 µM TTNPB or control vehicle (0.1% EtOH). TTNPB greatly expands expression of Znf703 into 
the dorsal and anterior domains, relative to control vehicle. Stage 11 embryos are shown in vegetal view with the 
dorsal lip at the top. Stage 12 and 16 are shown in dorsal view with anterior to the right. Stage 20 embryos are 
shown in anterior view. Stage 30 embryos are shown in lateral view with anterior to the right.
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(Fig. S6). However, by stage 27, we found that clarity in the segregation of migratory streams is lacking, and the 
otocyst is compromised (Fig. 6C–D’). This effect on Sox10 was nearly identical to Znf703 mis/overexpression 
induced before gastrulation (cf Fig. 6B,B’) or non-inducible Znf703 mis/overexpression (Fig. 4D,D’). We observe 
a slight improvement in the size and posterior-lateral positioning of the otocyst when DEX is provided at stage 
15, but epibranchial and lateral line patterning remain perturbed at tailbud stage. From this, we conclude that 
the early loss of Gdf3 and Wnt8 (Figs 5A,B and S5) by Znf703 mis/overexpression does not significantly impact 
Sox10 expression later. Hence, Znf703 has a different and separable function in mesoderm versus neural crest 
development. Finally, treatment with DEX at stage 19 showed minimal effect on Sox10 expression (Fig. 6E,E’).
Znf703 promotes anterior SOX2 expression at the expense of otic development. In tailbud 
embryos, Znf703 is strikingly absent from the otocyst, epibranchial placode, and lateral line, where Eya1 is nor-
mally expressed (Fig. 7A–C). Eya1 is a weak probe for double WISH, therefore, we stained with the stronger Sox10 
probe along with Znf703 to confirm that Znf703 is completely absent from the otocyst (Fig. 7D). Upon sectioning 
tailbud-stage embryos microinjected with Znf703 after gastrulation, we consistently observed the absence of an 
Figure 4. Overexpression of Znf703 mRNA inhibits neural crest migration. Embryos were injected unilaterally 
at 2- or 4-cell stage with either 0.5 ng Znf703 (A–F’) or control mCherry. (A–C) Znf703 mRNA reduces the 
lateral and anterior expression of Sox10, Twist, and Foxd3 in stage 19 embryos (shown in anterior view). Injected 
side is to the right of the dotted line, and is indicated by the magenta β-gal lineage tracer. (D’–F’) Znf703 mRNA 
inhibits Sox10 patterning, Twist, and Tfap2a in stage 27 embryos (shown in lateral view). (D–F) Uninjected side 
of the same embryo. Fractions represent the portion of embryos displaying the phenotype.
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otocyst on the injected side in transverse sections through the head (Fig. 7E,F). Similarly, in laterally-mounted 
whole embryos, confocal imaging through the surface towards the midline did not reveal an otocyst on the 
injected side (Fig. 7H), and otic markers Eya1 and Sox10 were significantly reduced (Fig. 7G,I). Concurrently, 
we observed a massive overgrowth of cells in the anterior neural tube (Fig. 7E), which we determined to be 
SOX2-positive (Fig. 7F). This proliferative effect is also observed when Znf703 is induced after gastrulation, and 
is only seen in the anterior domain: the degree of SOX2 expansion diminished in sections taken posterior to the 
otocyst (Fig. 7F). The fate of these SOX2-expressing cells remains unclear, because Sox2 is widely expressed in 
development. Perhaps one of the more well-known developmental processes of Sox2 is in the neurogenic lineage, 
but we found no increase in primary neurons when Znf703 is overexpressed (Fig. S7). Alternatively, increased 
Sox2 expression could be promoting cell proliferation without driving a specific cell fate.
Discussion
Znf703 is an RAR-inducible transcriptional repressor. Znf703 is an intriguing potential effector of 
cross-talk between RA, Wnt, Noggin, and Nodal signaling. Znf703 has been associated with both Nodal and 
Noggin6,35 and is a direct target of Wnt pathways8,11. Znf703 is induced by RA in P19 embryonal carcinoma cells 
and in zebrafish14,36 and was also identified by microarray to be RA-inducible the E8.5 mouse37. The data we have 
presented further affirms Znf703 as an RA responsive gene in vivo. Whether Znf703 is also a direct target of RAR 
is an open question. We found no discernable RAR binding site within 20 kilobases upstream or downstream of 
Znf703, or within the gene itself. Existing ChIP data in mouse in vitro studies do not identify Znf703 as a direct 
target38–40. This does not prove that the interaction between RAR and Znf703 is indirect, but rather indicates that 
additional, in vivo, ChIP analysis will be required to conclusively establish whether Znf703 is a direct or indirect 
target of RA. Furthermore, RAR occupancy on DNA does not necessarily equal transcriptional activation since 
RARs can act as repressors in the absence of RA41,42.
When Znf703 was originally characterized, it was hypothesized that the FKPY domain was recruiting the tran-
scriptional corepressor Groucho based on its similarity to Brinker and Elbow FKPY24,25 and Hucklebein FRPW26, 
domains that are required for Groucho interaction. Murine Zfp703 and Zfp503 have been named Zeppo1 and 
Zeppo29,43, that are undoubtedly referencing the relationship to Groucho and Zeppo Marx. However, deletion 
analysis in zebrafish showed that there was no effect on the Groucho interaction when the N-terminus and 
Figure 5. Overexpression of Znf703 mRNA reduces expression of Gdf3 and Wnt8, but not T or Fgf8. Embryos 
were injected unilaterally at 2- or 4-cell stage with either 0.5 ng Znf703 or control mCherry mRNA. Injected side 
is to the right of the dotted line, and is indicated by the magenta ß-gal lineage tracer. (A–C,F) Znf703 mRNA 
causes loss of Gdf3, knockdown of Wnt8, and weak knockdown or no change of T and Fgf8. Embryos are 
shown at stage 10.5/11 in vegetal view. (D,E) Control mRNA did not have any effect on Gdf3 or Wnt8. Fractions 
represent the portion of embryos displaying the phenotype. NC = No change.
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Figure 6. Znf703 impairs Sox10 expression at tailbud stage, when induced after stage 12 up until stage 19. (A) 
Schematic of ligand-inducible transcriptional repression by hGR-Znf703. In the absence of dexamethasone (DEX), 
hGR-ZNF703 is tethered in the cytoplasm by HSP90. In the presence of DEX, hGR-ZNF703 is free to enter the 
nucleus. Question marks indicate that Znf703 is not thought to bind DNA directly. (B–E’) Embryos were injected 
unilaterally with 0.2 ng hGR-Znf703 mRNA at 2- or 4-cell stage, then treated with 5 µM DEX or 0.05% DMSO 
vehicle at the stages indicated. Injected side is indicated by the magenta β-gal mRNA lineage tracer. Znf703 blurs 
the migratory streams of Sox10 expression when Znf703 is induced after gastrulation and prior to stage 19. Little 
effect on Sox10 is observed when embryos are treated with DEX at stage 19. DMSO treated embryos are pictured 
in Fig. S4. All embryos are shown in lateral view with anterior on the right, at stage 27. Fractions represent the 
portion of embryos displaying the phenotype in one time-course experiment from the same clutch of embryos. 
This experiment was repeated an additional time, and very similar results were obtained.
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FKPY of Znf703/Zeppo1 were removed5. In addition, the FKPY motif in Brinker did not affect the ability of a 
stripe2-Brinker transgene to repress dpp25. Similarly, we demonstrated that mutating the FKPY domain did not 
affect transcriptional repression, nor did it exacerbate or weaken phenotypes associated with wild type Znf703 
Figure 7. Znf703 is normally absent from the otocyst. Znf703 overexpression causes aberrant SOX2 expression 
and disappearance of otocyst. (A–D) Znf703 is absent from the otocyst as marked by Eya1 and Sox10, and lateral 
line placode as marked by Eya1, shown in lateral view at stage 27. Ot = otocyst; ll = lateral line; eb = epibranchial 
placodes. Embryos were injected unilaterally at the 2- or 4-cell stage with 0.5 ng Znf703 mRNA (E,G–I) or 0.2 ng 
hGR-Znf703 mRNA and treated with DEX at stage 12 (F). (E,F) Maximum intensity projections of Dapi nuclear 
stain and/or SOX2 from confocal images of transverse sections (expansion of SOX2 observed in 8/8 embryos 
sectioned). Otocysts were not found on the injected side in 60% of embryos. In the remaining 40% of embryos, 
the otocyst was reduced in size (red arrow). (G) Sox10 expression marks otocysts that are significantly reduced 
in size and positioned more rostral/ventral in the head compared to control (Stage 27 embryo in lateral view). 
(H) Maximum intensity projection of Dapi (false-colored in white) from confocal images through a laterally-
mounted stage 27 embryo. (I) Eya1 expression is reduced, particularly in the otic vesicle on the injected side 
(Stage 27 embryo in lateral view) (15/15 embryos). Red boxes in H and I highlight the otocyst on the uninjected 
side and its absence on the injected side.
1 0Scientific RepoRts |          (2019) 9:8275  | https://doi.org/10.1038/s41598-019-44722-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
expression on mesoderm or neural crest markers. Thus, we infer that transcriptional repression by Xenopus 
Znf703 requires the Buttonhead domain. Future studies will investigate how the Buttonhead domain of Znf703 
mediates transcriptional repression during embryonic development and whether a combination of domains is 
required for maximal repression, in vivo.
Znf703 overexpression hinders neural crest development after gastrulation. Misexpressing or 
overexpressing a transcriptional repressor from early stages in development can often result in confounding phe-
notypic effects28. Gain- and loss-of-function analysis of Znf703 both resulted in loss of neural crest genes Snai2 
and Sox10 6. We showed that Znf703 inhibits expression of mesodermal markers Gdf3 and Wnt8 at gastrula stage 
and disrupts neural crest migration and patterning in the neurula and tailbud stage embryo. The dorsolateral 
marginal zone in Xenopus, where Znf703 is co-expressed with Wnt8 and Gdf3, is thought to be responsible for 
neural crest induction29–31. Furthermore, if loss of Wnt8 in Znf703-injected embryos is indicative of Wnt levels in 
the early gastrula, then neural crest competence would be compromised32. Therefore, it is not inconceivable that 
early deficiency in Wnt8 and Gdf3 expression at gastrula stage would have direct consequences on neural crest 
later.
To test this possibility, we designed hormone-inducible Znf703 expression constructs. We found that Znf703 
is still fully capable of perturbing neural crest and placode patterning at tailbud stage when induced after stage 
12, thus demonstrating that Znf703 has a role in early mesoderm development that is separable from its effects 
on neural crest and placode. A proline- and tyrosine-rich domain in the C-terminus ensures Znf703 and Znf503 
nuclear localization4,43,44; however, with only one zinc finger present, it is assumed that these proteins lack the 
ability to bind DNA directly45. Znf703 and Znf503 are related to the SP family of proteins which can function 
as both co-activators and co-repressors46. Thus, Znf703 likely behaves as a transcriptional cofactor, potentially 
with multiple binding partners depending on the cellular context. Based on our results, it is plausible that Znf703 
possesses a different interactome in mesoderm versus neural crest, which is an interesting area of future study.
Our hormone-inducible Znf703 experiments clearly resolve early (gastrula) versus late (neurula) events, but 
we can also propose a role for Znf703 in induction/specification, delamination and migration of the neural crest. 
When Dex is administered at stage 15, the Znf703 protein is likely to translocate into the nucleus by around stage 
18 (two hours later47), when neural crest cells are beginning to segregate and migrate, but induction/specifica-
tion has already transpired48. At stage 18, we cannot detect any changes in neural crest patterning when Znf703 
is induced at stage 12 or stage 15. However, by stage 27, we observed significant loss of defined Sox10 migratory 
streams. These data are consistent with a model in which Znf703 is primarily affecting delamination/migration, 
which agrees with its known role in epithelial-mesenchymal transitions (EMTs) and regulation of E-cadherin9,43. 
Induction of Znf703 beyond stage 19 was no longer detrimental to neural crest patterning. Nevertheless, we 
did not evaluate bone, cartilage or pigment in tadpoles to completely rule out the role of Znf703 in neural crest 
differentiation.
Znf703-induced SOX2 expansion at the neural plate border. Our results and those of Hong, 2017 
have established that Znf703 is expressed in the neural plate border. The neural plate border is a small region 
where progenitors of multiple different lineages mingle and signal dynamically over very small distances1. 
Recently, this was shown at the single cell, molecular level where early neural plate stages show significant over-
lap of transcription factor expression that later become restricted to separate lineages2. Misexpression of Znf703 
expands Sox2 mRNA expression at the open neural plate stage 14/15, and this expansion seemed more pro-
nounced in the anterior6. In agreement with these data, we showed that Znf703 mis/overexpression causes prodi-
gious expansion of the SOX2 protein domain at tailbud stage, observable only in the head.
A preponderance of ectopic SOX2+  expressing cells found in the anterior neural plate of 
Znf703-overexpressing embryos will undoubtedly upset the balance of intricate signaling and lineage decisions 
occurring at the neural plate border. Misexpression of Sox2 in quail inhibits Slug expression and neural crest 
migration49. Sox3 gain-of-function delays neural crest induction, reduces migration, and disrupts branchial carti-
lage development, while promoting the neural progenitor fate50. The precedent for Sox2/3 overexpression altering 
the boundary between neural and non-neural ectoderm supports the argument that the SOX2 expansion we 
observe is causal to the loss of Foxd3 and Tfap2 in the early neurula. Nevertheless, the consequence of copious 
numbers of SOX2+ cells, induced by Znf703, is not easily interpretable given that the SoxB1 family is notoriously 
perplexing with respect to its spatial and temporal expression and regulation of proliferation/pluripotency, cell 
lineage, and differentiation. It is unclear whether extra SOX2+ cells are simply indicative of proliferation, without 
an associated lineage, or if SOX2 is preferentially driving a specific cell fate, at the expense of another. Inducible 
Eya1 overexpression phenocopies our results on Sox2, including the failure of the otic vesicle to form Fig. 7 51. 
These authors concluded that ectopic SoxB1 stabilized a placodal, neurogenic progenitor fate, at the expense of 
differentiation51. Similarly, we found that Znf703 did not increase N-tubulin expression after gastrulation, there-
fore, SOX2-expressing cells might commit cells towards a neurogenic lineage, but cannot drive differentiation 
without additional signals. As a result, the SOX2-expressing cells might later die, since they are unable to differen-
tiate at the correct time and place in the embryo. Alternatively, the ectopic SOX2+ cells contribute to neural crest 
and epidermal derivatives as found recently in chicken by Roellig and colleagues, 20172. Deciphering the identity 
of Znf703-induced SOX2+ cells, is an interesting area of future study.
Znf703 and otic development. Our group has a long-standing interest in RA and placode development. 
We previously found that RA is essential for establishing the posterior-lateral boundary of the preplacodal ecto-
derm18. Znf703 (orthologous to the invertebrate no ocelli) has been linked to sensorineural development through-
out evolution52,53. Nlz morphant zebrafish fail to close the optic fissure in the ventral region of the developing 
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eye54. Znf503 is a negative regulator of Gata355 which is expressed in the preplacodal ectoderm56 and is a critical 
factor in specifying the prosensory domain of the otocyst57,58. Znf703 is also cistronic to Fgfr1, important for 
maintaining Sox2+ progenitors in the Organ of Corti59.
In this current study, we noted that Znf703 is almost an inverted image of Eya1, as revealed by double WISH. 
Transverse sections through Znf703-injected embryos at the r5/r6 level showed otocyst absence or reduction in 
size, as well as changes in its posterior-lateral position in the head, and subsequent loss of Eya1 and Sox10 otic 
expression. The implication is that local Znf703 must be specifically cleared or down-regulated in the developing 
otocyst, otherwise Znf703 would inappropriately repress genes required for ear development. The developing 
embryo is exquisitely sensitive to RA concentration; therefore, local retinoid levels in the otocyst must be tightly 
regulated (reviewed in60). Local boundaries of RA during development are often established by opposing Fgf 
signals61. One possible scenario is that RA induces Znf703 to inhibit Gata3, whose primary target is Fgf1062, thus 
RA would inhibit FGF signaling via Znf703. A second possibility concerns RA-Wnt interactions. Wnt signaling is 
required for specifying the otic fate, and when Wnt is inhibited, the placode territory instead becomes epidermal 
or epibranchial63,64. Others have established Znf703 as a Wnt inhibitor; therefore, Znf703 could regulate the fate 
decision and/or boundary delineation of the epidermal/epibranchial (low Wnt) versus otic (high Wnt) lineages 
by modulating Wnt signaling.
Conclusion
Znf703 is an important point of crosstalk among RAR, WNT, and TGFβ (among other) signaling pathways, and 
exhibits a complex expression pattern early in the circumblastoporal ring and neural plate border, and later in 
crest, placode, hindbrain, and somites. In this paper, we focused on addressing the role of Znf703 in neural crest 
and otic development, but Znf703 is likely to affect other lineages at the neural plate border such as anterior pla-
code (e.g., lens) and mesodermal derivatives (somites). Znf703 is poised to interpret local RA levels while, simul-
taneously, modulating Wnt signaling. Therefore, Znf703 is anticipated to be an important ingredient in many 
embryonic processes where Wnt-RA crosstalk is required. Znf703 is unlikely to bind DNA directly, and therefore, 
Znf703 may potentially be promiscuous in its interaction with other transcription factors. Detailed biochemical 
analysis will be required to understand how Znf703 functions, which co-repressor(s) interacts with Znf703, and 
which exact domain, or combination of domains are responsible for transcriptional repression. Finally, the trans-
lational implications of RA-regulation of Znf703 are intriguing because RA is known to improve outcomes in a 
limited number of cancers65, but Znf703 acts an oncogene to promote adult luminal B breast cancer in humans35.
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